IL152783A0 - 2-aminocarbonyl-9h-purine derivatives - Google Patents

2-aminocarbonyl-9h-purine derivatives

Info

Publication number: IL152783A0
Authority: IL; Israel
Prior art keywords: aminocarbonyl; purine derivatives; purine; derivatives
Prior art date: 2000-06-06

Application number

IL15278301A

Other languages

English (en)

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-06

Filing date

2001-06-05

Publication date

2003-06-24

2000-06-06 Priority claimed from GB0014048A external-priority patent/GB0014048D0/en

2000-10-11 Priority claimed from GB0024920A external-priority patent/GB0024920D0/en

2001-06-05 Application filed by Pfizer filed Critical Pfizer

2003-06-24 Publication of IL152783A0 publication Critical patent/IL152783A0/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
- C07H19/167—Purine radicals with ribosyl as the saccharide radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Pulmonology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Dermatology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Cardiology (AREA)
Gynecology & Obstetrics (AREA)
Rheumatology (AREA)
Immunology (AREA)
Psychiatry (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Biochemistry (AREA)
Pain & Pain Management (AREA)
Pregnancy & Childbirth (AREA)
Urology & Nephrology (AREA)
Obesity (AREA)
Hematology (AREA)
Vascular Medicine (AREA)
Emergency Medicine (AREA)

IL15278301A 2000-06-06 2001-06-05 2-aminocarbonyl-9h-purine derivatives IL152783A0 (en)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
GB0014048A GB0014048D0 (en)	2000-06-06	2000-06-06	Purine derivatives
GB0018246A GB0018246D0 (en)	2000-06-06	2000-07-25	Purine derivatives
GB0024920A GB0024920D0 (en)	2000-06-06	2000-10-11	Purine derivatives
PCT/IB2001/000973 WO2001094368A1 (en)	2000-06-06	2001-06-05	2-aminocarbonyl-9h-purine derivatives

Publications (1)

Publication Number	Publication Date
IL152783A0 true IL152783A0 (en)	2003-06-24

Family

ID=27255754

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
IL15278301A IL152783A0 (en)	2000-06-06	2001-06-05	2-aminocarbonyl-9h-purine derivatives
IL184144A IL184144A (en)	2000-06-06	2007-06-21	Intermediates used in the preparation of derivatives of 2-aminocarbonyl-H9-purine

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
IL184144A IL184144A (en)	2000-06-06	2007-06-21	Intermediates used in the preparation of derivatives of 2-aminocarbonyl-H9-purine

Country Status (34)

Country	Link
EP (1)	EP1292604B1 (no)
JP (2)	JP4129176B2 (no)
KR (1)	KR100484704B1 (no)
CN (1)	CN1249074C (no)
AR (1)	AR030289A1 (no)
AT (1)	ATE431356T1 (no)
AU (2)	AU6053701A (no)
BG (1)	BG107216A (no)
BR (1)	BR0111263A (no)
CA (1)	CA2414018C (no)
CU (1)	CU23240B7 (no)
CZ (1)	CZ20023875A3 (no)
DE (1)	DE60138702D1 (no)
DK (1)	DK1292604T3 (no)
DZ (1)	DZ3439A1 (no)
EA (1)	EA004983B1 (no)
EE (1)	EE200200678A (no)
ES (1)	ES2324816T3 (no)
GC (1)	GC0000287A (no)
HK (2)	HK1054042A1 (no)
HR (1)	HRP20020960A2 (no)
HU (1)	HUP0301330A3 (no)
IL (2)	IL152783A0 (no)
IS (1)	IS6599A (no)
MA (1)	MA26910A1 (no)
MX (1)	MXPA02012033A (no)
NO (1)	NO324426B1 (no)
NZ (1)	NZ522184A (no)
OA (1)	OA12279A (no)
PA (1)	PA8518801A1 (no)
PL (1)	PL360435A1 (no)
SK (1)	SK16752002A3 (no)
TW (1)	TWI227240B (no)
WO (1)	WO2001094368A1 (no)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7378400B2 (en)	1999-02-01	2008-05-27	University Of Virginia Patent Foundation	Method to reduce an inflammatory response from arthritis
TWI227240B (en) *	2000-06-06	2005-02-01	Pfizer	2-aminocarbonyl-9H-purine derivatives
US6921753B2 (en)	2000-06-27	2005-07-26	Pfizer Inc	Purine derivatives
US20030013675A1 (en) *	2001-05-25	2003-01-16	Boehringer Ingelheim Pharma Kg	Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases
CA2460911C (en)	2001-10-01	2011-08-30	University Of Virginia Patent Foundation	2-propynyl adenosine analogs having a2a agonist activity and compositions thereof
US6974803B2 (en)	2001-12-06	2005-12-13	Pfizer Inc	Pharmaceutical combination
GB0129270D0 (en) *	2001-12-06	2002-01-23	Pfizer Ltd	Pharmaceutical combination
GB0129273D0 (en) *	2001-12-06	2002-01-23	Pfizer Ltd	Crystalline drug form
AU2003234716A1 (en) *	2002-04-10	2003-10-27	Joel M. Linden	Use of a2a adenosine receptor agonists for the treatment of inflammatory diseases
US20060178403A1 (en) *	2003-03-07	2006-08-10	Neurocrine Biosciences, Inc.	Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
WO2004080411A2 (en) *	2003-03-07	2004-09-23	Neurocrine Biosciences, Inc.	Melanin-concentrating hormone receptor antagonists and compositions and methods related thereto
AR044519A1 (es)	2003-05-02	2005-09-14	Novartis Ag	Derivados de piridin-tiazol amina y de pirimidin-tiazol amina
US7335648B2 (en)	2003-10-21	2008-02-26	Inspire Pharmaceuticals, Inc.	Non-nucleotide composition and method for inhibiting platelet aggregation
JP2007509180A (ja)	2003-10-21	2007-04-12	インスパイアーファーマシューティカルズ，インコーポレイティド	疼痛を治療するための、非ヌクレオチド組成物および方法
US7368438B2 (en)	2003-10-21	2008-05-06	Inspire Pharmaceuticals, Inc.	Non-nucleotide compositions and method for inhibiting platelet aggregation
US7749981B2 (en)	2003-10-21	2010-07-06	Inspire Pharmaceuticals, Inc.	Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
GB0401334D0 (en)	2004-01-21	2004-02-25	Novartis Ag	Organic compounds
GB0411056D0 (en)	2004-05-18	2004-06-23	Novartis Ag	Organic compounds
NZ585697A (en)	2004-08-02	2011-12-22	Univ Virginia Patent Found	2-propynyl adenosine analogs with modified 5'-ribose groups having A2A agonist activity
US7442687B2 (en)	2004-08-02	2008-10-28	The University Of Virginia Patent Foundation	2-polycyclic propynyl adenosine analogs having A2A agonist activity
GT200500281A (es)	2004-10-22	2006-04-24	Novartis Ag	Compuestos organicos.
GB0424284D0 (en)	2004-11-02	2004-12-01	Novartis Ag	Organic compounds
GB0426164D0 (en)	2004-11-29	2004-12-29	Novartis Ag	Organic compounds
US7932376B2 (en)	2005-05-05	2011-04-26	Inspire Pharmaceuticals, Inc.	Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
GB0510390D0 (en)	2005-05-20	2005-06-29	Novartis Ag	Organic compounds
AR058104A1 (es)	2005-10-21	2008-01-23	Novartis Ag	Compuestos organicos
GB0601951D0 (en)	2006-01-31	2006-03-15	Novartis Ag	Organic compounds
AR060607A1 (es)	2006-04-21	2008-07-02	Novartis Ag	Derivados de purina,composiciones farmaceuticas que los contienen, metodo de preparacion y usos en enfermedades obstructivas o inflamatorias de las vias respiratorias.
WO2008037477A1 (en)	2006-09-29	2008-04-03	Novartis Ag	Pyrazolopyrimidines as p13k lipid kinase inhibitors
AU2007315234A1 (en)	2006-10-30	2008-05-08	Novartis Ag	Heterocyclic compounds as antiinflammatory agents
ES2442930T3 (es)	2008-01-11	2014-02-14	Novartis Ag	Pirimidinas como inhibidores de cinasas
EA019755B1 (ru) *	2008-06-19	2014-06-30	Такеда Фармасьютикал Компани Лимитед	Гетероциклическое соединение и его применение
SI2391366T1 (sl)	2009-01-29	2013-01-31	Novartis Ag	Substituirani benzimidazoli za zdravljenje astrocitomov
WO2010136940A1 (en)	2009-05-29	2010-12-02	Pfizer Limited	Novel glucocorticoid receptor agonists
US8389526B2 (en)	2009-08-07	2013-03-05	Novartis Ag	3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
WO2011018454A1 (en)	2009-08-12	2011-02-17	Novartis Ag	Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation
CA2771532C (en)	2009-08-17	2021-03-23	Intellikine, Inc.	Heterocyclic compounds and uses thereof
IN2012DN01453A (no)	2009-08-20	2015-06-05	Novartis Ag
US8637516B2 (en)	2010-09-09	2014-01-28	Irm Llc	Compounds and compositions as TRK inhibitors
WO2012034095A1 (en)	2010-09-09	2012-03-15	Irm Llc	Compounds and compositions as trk inhibitors
WO2012107500A1 (en)	2011-02-10	2012-08-16	Novartis Ag	[1, 2, 4] triazolo [4, 3 -b] pyridazine compounds as inhibitors of the c-met tyrosine kinase
WO2012116237A2 (en)	2011-02-23	2012-08-30	Intellikine, Llc	Heterocyclic compounds and uses thereof
CA2828219A1 (en)	2011-02-25	2012-08-30	Irm Llc	Pyrazolo [1,5-a] pyridines as trk inhibitors
ES2691650T3 (es)	2011-09-15	2018-11-28	Novartis Ag	3-(quinolin-6-il-tio)-[1,2,4]-triazolo-[4,3-a]-piridinas 6-sustituidas como inhibidores de tirosina quinasa c-Met
EP2793893A4 (en)	2011-11-23	2015-07-08	Intellikine Llc	IMPROVED TREATMENT REGIMES USING MTOR INHIBITORS
EP2834246B1 (en)	2012-04-03	2021-07-28	Novartis AG	Combination products with tyrosine kinase inhibitors and their use
WO2014151147A1 (en)	2013-03-15	2014-09-25	Intellikine, Llc	Combination of kinase inhibitors and uses thereof
WO2015084804A1 (en)	2013-12-03	2015-06-11	Novartis Ag	Combination of mdm2 inhibitor and braf inhibitor and their use
WO2016011658A1 (en)	2014-07-25	2016-01-28	Novartis Ag	Combination therapy
CA2954862A1 (en)	2014-07-31	2016-02-04	Novartis Ag	Combination therapy
TW202140550A (zh)	2020-01-29	2021-11-01	瑞士商諾華公司	使用抗ｔｓｌｐ抗體治療炎性或阻塞性氣道疾病之方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BR9914526A (pt) *	1998-10-16	2001-07-03	Pfizer	Derivados de adenina
GB9913932D0 (en) *	1999-06-15	1999-08-18	Pfizer Ltd	Purine derivatives
TWI227240B (en) *	2000-06-06	2005-02-01	Pfizer	2-aminocarbonyl-9H-purine derivatives

2001
- 2001-05-31 TW TW090113146A patent/TWI227240B/zh not_active IP Right Cessation
- 2001-06-04 AR ARP010102656A patent/AR030289A1/es active IP Right Grant
- 2001-06-05 WO PCT/IB2001/000973 patent/WO2001094368A1/en active Application Filing
- 2001-06-05 EA EA200201179A patent/EA004983B1/ru not_active IP Right Cessation
- 2001-06-05 CA CA002414018A patent/CA2414018C/en not_active Expired - Fee Related
- 2001-06-05 AU AU6053701A patent/AU6053701A/xx active Pending
- 2001-06-05 EP EP01934242A patent/EP1292604B1/en not_active Expired - Lifetime
- 2001-06-05 EE EEP200200678A patent/EE200200678A/xx unknown
- 2001-06-05 AU AU2001260537A patent/AU2001260537B2/en not_active Ceased
- 2001-06-05 AT AT01934242T patent/ATE431356T1/de not_active IP Right Cessation
- 2001-06-05 MX MXPA02012033A patent/MXPA02012033A/es active IP Right Grant
- 2001-06-05 JP JP2002501916A patent/JP4129176B2/ja not_active Expired - Fee Related
- 2001-06-05 ES ES01934242T patent/ES2324816T3/es not_active Expired - Lifetime
- 2001-06-05 SK SK1675-2002A patent/SK16752002A3/sk unknown
- 2001-06-05 CN CNB018108024A patent/CN1249074C/zh not_active Expired - Fee Related
- 2001-06-05 CZ CZ20023875A patent/CZ20023875A3/cs unknown
- 2001-06-05 HU HU0301330A patent/HUP0301330A3/hu unknown
- 2001-06-05 GC GCP20011415 patent/GC0000287A/en active
- 2001-06-05 KR KR10-2002-7016606A patent/KR100484704B1/ko not_active IP Right Cessation
- 2001-06-05 DZ DZ013439A patent/DZ3439A1/fr active
- 2001-06-05 IL IL15278301A patent/IL152783A0/xx active IP Right Grant
- 2001-06-05 NZ NZ522184A patent/NZ522184A/en unknown
- 2001-06-05 BR BR0111263-5A patent/BR0111263A/pt not_active IP Right Cessation
- 2001-06-05 PL PL36043501A patent/PL360435A1/xx not_active Application Discontinuation
- 2001-06-05 OA OA1200200363A patent/OA12279A/en unknown
- 2001-06-05 DK DK01934242T patent/DK1292604T3/da active
- 2001-06-05 DE DE60138702T patent/DE60138702D1/de not_active Expired - Lifetime
- 2001-06-06 PA PA20018518801A patent/PA8518801A1/es unknown
2002
- 2002-10-23 BG BG107216A patent/BG107216A/bg unknown
- 2002-10-29 IS IS6599A patent/IS6599A/is unknown
- 2002-11-26 CU CU20020281A patent/CU23240B7/es not_active IP Right Cessation
- 2002-12-02 MA MA26930A patent/MA26910A1/fr unknown
- 2002-12-04 NO NO20025821A patent/NO324426B1/no not_active IP Right Cessation
- 2002-12-05 HR HR20020960A patent/HRP20020960A2/hr not_active Application Discontinuation
2003
- 2003-09-05 HK HK03106312A patent/HK1054042A1/xx not_active IP Right Cessation
2006
- 2006-09-05 HK HK06109837A patent/HK1089447A1/xx not_active IP Right Cessation
2007
- 2007-06-21 IL IL184144A patent/IL184144A/en not_active IP Right Cessation
2008
- 2008-01-15 JP JP2008005804A patent/JP2008150383A/ja active Pending

Also Published As

Publication number	Publication date
BG107216A (bg)	2003-05-30
DZ3439A1 (fr)	2001-12-13
IS6599A (is)	2002-10-29
KR20030032962A (ko)	2003-04-26
CU23240B7 (es)	2007-10-17
HRP20020960A2 (en)	2005-02-28
CA2414018A1 (en)	2001-12-13
HUP0301330A2 (hu)	2003-08-28
MXPA02012033A (es)	2003-04-25
DE60138702D1 (de)	2009-06-25
NO20025821L (no)	2003-02-04
AR030289A1 (es)	2003-08-20
GC0000287A (en)	2006-11-01
DK1292604T3 (da)	2009-06-15
WO2001094368A1 (en)	2001-12-13
ATE431356T1 (de)	2009-05-15
EA200201179A1 (ru)	2003-04-24
SK16752002A3 (sk)	2004-05-04
KR100484704B1 (ko)	2005-04-22
PA8518801A1 (es)	2002-09-17
HK1054042A1 (en)	2003-11-14
HK1089447A1 (en)	2006-12-01
EP1292604A1 (en)	2003-03-19
IL184144A0 (en)	2007-10-31
OA12279A (en)	2003-01-01
IL184144A (en)	2008-11-26
NO20025821D0 (no)	2002-12-04
CN1249074C (zh)	2006-04-05
CN1434830A (zh)	2003-08-06
AU6053701A (en)	2001-12-17
PL360435A1 (en)	2004-09-06
CA2414018C (en)	2007-10-16
CZ20023875A3 (cs)	2004-02-18
BR0111263A (pt)	2003-06-17
NZ522184A (en)	2004-05-28
AU2001260537B2 (en)	2006-05-25
HUP0301330A3 (en)	2005-02-28
MA26910A1 (fr)	2004-12-20
ES2324816T3 (es)	2009-08-17
NO324426B1 (no)	2007-10-08
JP2008150383A (ja)	2008-07-03
JP4129176B2 (ja)	2008-08-06
EP1292604B1 (en)	2009-05-13
EE200200678A (et)	2004-06-15
JP2003535871A (ja)	2003-12-02
EA004983B1 (ru)	2004-10-28
TWI227240B (en)	2005-02-01

Legal Events

Date	Code	Title	Description
2009-09-15	FF	Patent granted
2009-09-15	KB	Patent renewed

Publication	Publication Date	Title
EG22695A (en)	2003-06-30	Novel phenyl-propargylether derivatives
HUP0301330A3 (en)	2005-02-28	2-aminocarbonyl-9h-purine derivatives
HRP20030055A2 (en)	2005-02-28	4-phenyl-pyridine derivatives
IL150841A0 (en)	2003-02-12	1h-imidazopyridine derivatives
IL155103A0 (en)	2003-10-31	Substituted c-cyclohexylmethylamine derivatives
HUP0300562A3 (en)	2006-02-28	Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the
IL155106A0 (en)	2003-10-31	Substituted 1-aminobutan-3-ol derivatives
IL150557A0 (en)	2003-02-12	Substituted aminomethyl-phenyl-cyclohexane derivatives
PL356565A1 (en)	2004-06-28	Aminosulfonylbiphenyl derivatives
IL150558A0 (en)	2003-02-12	Aminomethyl-phenyl-cyclohexanone derivatives
IL155104A0 (en)	2003-10-31	5-amino-1-pentene-3-ol substituted derivatives
EP1408955A4 (en)	2006-09-06	NEW METALLOTEXAPHYRINE DERIVATIVES
IL151598A0 (en)	2003-04-10	2-phenylpyran-4-one derivatives
HK1054937A1 (en)	2003-12-19	1-Methylcarbapenem derivatives
GB0021639D0 (en)	2000-10-18	Maurotoxin derivatives
SI1322590T1 (sl)	2007-10-31	Substituirani 5-amino-1-penten-3-olni derivati
SI1246793T1 (en)	2005-06-30	Substituted aminomethyl-phenyl-cyclohexane derivatives
GB0015959D0 (en)	2000-08-23	T-Treble-S
GB0005329D0 (en)	2000-04-26	Worrawee innagen
GB0011265D0 (en)	2000-06-28	Tri-cast strimmer
GB0015284D0 (en)	2000-08-16	Quadricycles
GB0000841D0 (en)	2000-03-08	Pansticker
GB0005657D0 (en)	2000-05-03	Ic2cu-idu